AT1 atomo diagnostics limited

Access Bio,'Surge' in US Approval of Corona 19 Antigen Diagnosis...

  1. 1,568 Posts.
    lightbulb Created with Sketch. 143
    Access Bio,'Surge' in US Approval of Corona 19 Antigen Diagnosis Kit

    Han Soo-yeon

    Input 2020.10.12 09:19

    Revision 2020.10.12 09:19

    comment 0dog

    Accessbio surged as it obtained emergency use approval (EUA) from the US Food and Drug Administration (FDA) for a rapid diagnosis kit for the novel coronavirus infection (Corona 19) antigen.

    As of 9:15 am on the 12th, Access Bio in the KOSDAQ market is trading at 34,000 won, up 25.69% (6,950 won) compared to the previous trading day.

    On the 10th, Accessbio announced on the 10th that its Corona 19 antigen rapid diagnosis kit'CareStart™ COVID-19 Antigen' has obtained emergency approval from the US FDA. This kit is a product that can quickly diagnose the presence of corona infection within 10 to 15 minutes by collecting a patient's sample from the nasopharynx and immunochromatography.


    This new looks very positive to me : ) . just waiting on the approval of CareStart COVID-19 IgM/IgG. lol
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
0.000(0.00%)
Mkt cap ! $10.31M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
12 3821439 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 1397440 5
View Market Depth
Last trade - 16.21pm 04/07/2025 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.